Clinical trial
Multicenter Pilot Study To Define The Marker As An Alternate For Tropism Assay
NCT00496782 · ViiV Healthcare, Industry · Terminated
Key facts
| NCT number | NCT00496782 |
|---|---|
| Title | Multicenter Pilot Study To Define The Marker As An Alternate For Tropism Assay |
| Official title | Surrogate Marker For Tropism-A Multi-Center, Open Label, Pilot Study |
| Lead sponsor | ViiV Healthcare, Industry |
| Collaborators | Pfizer Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug, Procedure |
| Interventions | maraviroc, Trofile Assay and HIV RNA quantification assay |
| Enrollment | 16 |
| Start date | Jul 1, 2007 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Jul 4, 2007 |
| Last update posted | Jan 30, 2019 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: